100,000
Participants
Start Date
August 31, 2016
Primary Completion Date
September 1, 2026
Study Completion Date
September 1, 2026
Complete a health questionnaire
Complete a health history questionnaire.
Provide a saliva sample for genetic testing
Provide a saliva sample for testing of 9 genes and a panel of single nucleotide polymorphisms (SNPs) that influence breast cancer risk
Screening advice based on a comprehensive risk assessment
Receive a screening schedule recommendation
Screening advice based on a basic risk assessment
Receive a screening schedule recommendation
RECRUITING
Weill Cornell Medicine, New York
RECRUITING
TopLine MD Alliance, Miami
RECRUITING
University of Alabama at Birmingham, Birmingham
ACTIVE_NOT_RECRUITING
Edith Sanford Breast Center, Sioux Falls
RECRUITING
University of Chicago, Chicago
ACTIVE_NOT_RECRUITING
Louisiana State University, New Orleans
RECRUITING
University of California Los Angeles, Los Angeles
RECRUITING
University of California San Diego, San Diego
RECRUITING
University of California Irvine, Irvine
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
University of California Davis, Sacramento
Collaborators (2)
Patient-Centered Outcomes Research Institute
OTHER
Robert Wood Johnson Foundation
OTHER
Color Genomics, Inc.
INDUSTRY
Salesforce
UNKNOWN
National Cancer Institute (NCI)
NIH
Safeway Foundation
UNKNOWN
United States Department of Defense
FED
Breast Cancer Research Foundation
OTHER
University of California, San Francisco
OTHER